{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:27:25Z","timestamp":1777498045404,"version":"3.51.4"},"reference-count":45,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,7,13]],"date-time":"2025-07-13T00:00:00Z","timestamp":1752364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clinical Hemorheology and Microcirculation"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Borderline ovarian tumors (BOTs) represent a rare group of neoplasms exhibiting abnormal epithelial proliferation with cellular atypia while lacking stromal invasion or infiltrative destructive growth. And postoperative recurrence may be associated with histological features and lymph node status. Therefore, preoperative prediction of BOTs\u2019 histological characteristics and lymph node status is of paramount importance for formulating surgical plans and follow-up treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the value of conventional ultrasound (US) and contrast-enhanced ultrasound (CEUS) characteristics for preoperative identification of histological features and lymph node status in BOTs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with pathologically confirmed primary BOTs were enrolled, which classified into high-risk and low-risk groups based on whether the presence of at least one of microinvasion, micropapillary pattern, extraovarian implantation, or lymph node invasion. CEUS was performed at the maximal solid tumor component identified on gray-scale imaging, with bolus injection of contrast agent and dynamic recording of the wash-in to wash-out phases for quantitative contrast kinetics analysis. A comparative analysis of US and CEUS characteristics was conducted between the groups, with subsequent longitudinal assessment of recurrence-free survival (RFS) curves employing Kaplan-Meier methodology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study comprised 58 patients with BOTs, stratified into low-risk (n\u2009=\u200937) and high-risk (n\u2009=\u200921) groups, with mean patient ages of 42.8\u2009\u00b1\u200911.8 years. No statistically significant differences were observed in tumor size (maximum diameter,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.840) or location (unilateral versus bilateral,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.077) between the two groups on US. The type of tumor, proportion of solid components, and color score were observed to statistically significantly differ between the two groups (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Iso- or hyper-enhancement, early or synchronously wash-in, and early wash-out were more likely to occur in the high-risk group (16\/21, 76.2%; 11\/21, 52.4%; 11\/21, 52.4%) than in the low-risk group (15\/37, 40.5%; 5\/37, 13.5%; 9\/37, 24.3%). In quantitative parameters, there were significant differences in MeanLin, PE, RT, TTP, WiR, WiPI, WoAUC, WiWoAUC, FT, and WoR between the two groups (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). During the follow-up, there were 3 cases recurrence in the high-risk group, while no recurrence was observed in the low-risk group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The combination of US and CEUS is capable of facilitating preoperative prediction of the histological features and lymph node status of BOTs, and holds potential value for identifying the recurrence risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/13860291251359096","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T06:17:57Z","timestamp":1752473877000},"page":"174-184","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative prediction of the histological features and lymph nodes status of borderline ovarian tumors: The role of conventional ultrasound and contrast-enhanced ultrasound"],"prefix":"10.1177","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6390-8294","authenticated-orcid":false,"given":"Luping","family":"Liu","sequence":"first","affiliation":[{"name":"Ultrasound Medical Center, Lanzhou University Second Hospital, Lanzhou, China"},{"name":"Gansu Province Clinical Research Center for Ultrasonography, Lanzhou, China"},{"name":"Gansu Province Medical Engineering Research Center for Intelligence Ultrasound, Lanzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Huang","sequence":"additional","affiliation":[{"name":"Ultrasound Medical Center, Lanzhou University Second Hospital, Lanzhou, China"},{"name":"Gansu Province Clinical Research Center for Ultrasonography, Lanzhou, China"},{"name":"Gansu Province Medical Engineering Research Center for Intelligence Ultrasound, Lanzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Zhu","sequence":"additional","affiliation":[{"name":"Ultrasound Medical Center, Lanzhou University Second Hospital, Lanzhou, China"},{"name":"Gansu Province Clinical Research Center for Ultrasonography, Lanzhou, China"},{"name":"Gansu Province Medical Engineering Research Center for Intelligence Ultrasound, Lanzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[{"name":"Ultrasound Medical Center, Lanzhou University Second Hospital, Lanzhou, China"},{"name":"Gansu Province Clinical Research Center for Ultrasonography, Lanzhou, China"},{"name":"Gansu Province Medical Engineering Research Center for Intelligence Ultrasound, Lanzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9725-1743","authenticated-orcid":false,"given":"Fang","family":"Nie","sequence":"additional","affiliation":[{"name":"Ultrasound Medical Center, Lanzhou University Second Hospital, Lanzhou, China"},{"name":"Gansu Province Clinical Research Center for Ultrasonography, Lanzhou, China"},{"name":"Gansu Province Medical Engineering Research Center for Intelligence Ultrasound, Lanzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,7,13]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/his.14609"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0139"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000282"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2020.101965"},{"key":"e_1_3_3_6_2","first-page":"239","article-title":"Borderline ovarian tumours: CNGOF guidelines for clinical practice - epidemiological aspects and risk factors","volume":"48","author":"Ouldamer L","year":"2020","unstructured":"Ouldamer L, Body G, Dara\u00ef E, et al. Borderline ovarian tumours: CNGOF guidelines for clinical practice - epidemiological aspects and risk factors. Gynecol Obstet Fertil Senol 2020; 48: 239\u2013247.","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-11-13"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-023-2775-9"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-020-05652-w"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11131922"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.13844"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-020-05716-x"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0b013e3181c187cb"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2010.11.016"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2023-005214"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030890"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-020-2163-7"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2018.1433656"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-023-01253-8"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-07113-z"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.2607"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.12276"},{"key":"e_1_3_3_23_2","article-title":"The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version)","volume":"39","author":"Sidhu PS","year":"2018","unstructured":"Sidhu PS, Cantisani V, Dietrich CF, et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version). Ultraschall Med 2018; 39: e2\u2013e44.","journal-title":"Ultraschall Med"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.13926"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2023.05.012"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.968759"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-052830"},{"key":"e_1_3_3_28_2","first-page":"523","article-title":"The multimodal ultrasound features of ovarian serous surface papillary borderline tumor","volume":"3","author":"Xie L","year":"2022","unstructured":"Xie L, Liu X, Li H, et al. The multimodal ultrasound features of ovarian serous surface papillary borderline tumor. Womens Health Rep (New Rochelle) 2022; 3: 523\u2013532.","journal-title":"Womens Health Rep (New Rochelle)"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2018.07.004"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.20283"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.6099"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.07.024"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-020-02688-z"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.1823"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.11.015"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2019191150"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.3233\/CH-242173"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.3233\/CH-231944"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.3233\/CH-248102"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2024.05.021"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2024.05.024"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.3233\/CH-249103"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.3233\/CH-239102"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.70.8594"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.3233\/CH-200898"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.3233\/CH-248111"}],"container-title":["Clinical Hemorheology and Microcirculation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13860291251359096","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13860291251359096","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13860291251359096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:07:32Z","timestamp":1777388852000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13860291251359096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,13]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1177\/13860291251359096"],"URL":"https:\/\/doi.org\/10.1177\/13860291251359096","relation":{},"ISSN":["1386-0291","1875-8622"],"issn-type":[{"value":"1386-0291","type":"print"},{"value":"1875-8622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,13]]}}}